Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Current Deferred Revenue (2017 - 2022)

Zai Lab's Current Deferred Revenue history spans 6 years, with the latest figure at $26.9 million for Q1 2022.

  • On a quarterly basis, Current Deferred Revenue rose 61.47% to $26.9 million in Q1 2022 year-over-year; TTM through Mar 2022 was $26.9 million, a 61.47% increase, with the full-year FY2021 number at $27.5 million, up 63.04% from a year prior.
  • Current Deferred Revenue hit $26.9 million in Q1 2022 for Zai Lab, down from $27.5 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for ZLAB hit a ceiling of $27.5 million in Q4 2021 and a floor of $2.1 million in Q4 2018.
  • Historically, Current Deferred Revenue has averaged $16.0 million across 5 years, with a median of $17.2 million in 2020.
  • Biggest five-year swings in Current Deferred Revenue: dropped 13.79% in 2018 and later surged 485.14% in 2020.
  • Tracing ZLAB's Current Deferred Revenue over 5 years: stood at $2.1 million in 2018, then surged by 39.58% to $2.9 million in 2019, then surged by 485.14% to $16.9 million in 2020, then soared by 63.04% to $27.5 million in 2021, then dropped by 2.15% to $26.9 million in 2022.
  • Business Quant data shows Current Deferred Revenue for ZLAB at $26.9 million in Q1 2022, $27.5 million in Q4 2021, and $17.5 million in Q3 2021.